These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39177793)

  • 1. Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.
    De Santis M; Tonutti A; Motta F; Todisco G; Manes N; Milanesi C; Caselli R; Albertazzi S; Bonometti A; Selmi C; Della Porta MG
    Ann Hematol; 2024 Nov; 103(11):4789-4791. PubMed ID: 39177793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEXAS syndrome: An update.
    Khitri MY; Hadjadj J; Mekinian A; Jachiet V
    Joint Bone Spine; 2024 Jul; 91(4):105700. PubMed ID: 38307404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic Mutations in
    Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
    N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome.
    Ospina Cardona D; Rodriguez-Pinto I; Iosim S; Bonet N; Mensa-Vilaro A; Wong MK; Ho G; Tormo M; Yagüe J; Shon W; Wallace DJ; Casals F; Beck DB; Abuav R; Arostegui JI
    Rheumatology (Oxford); 2024 Oct; 63(10):2897-2902. PubMed ID: 38552317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern.
    Iannone C; Pellico MR; Campochiaro C; Tescaro L; Zompatori M; Caminati A; Harari S; Caporali R
    Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent orbital inflammation associated with VEXAS syndrome.
    Beecher MB; Tong JY; Halliday LA; Hissaria P; Selva D
    Orbit; 2024 Jun; 43(3):350-353. PubMed ID: 36168114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
    Lecoeuvre H; Le Gall F; Le Naoures C; Vignon-Pennamen MD; Lamaison C; Kammerer-Jacquet SF; Lescoat A; Oger E; Pastoret C; Dupuy A
    Clin Exp Dermatol; 2024 Jul; 49(8):825-833. PubMed ID: 38366665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I diagnose and manage VEXAS syndrome.
    Hagiya A; Siddiqi IN; Wang E; Lu CM
    Am J Clin Pathol; 2024 Jul; 162(1):28-40. PubMed ID: 38511841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEXAS syndrome in dermatology.
    Afsahi V; Christensen RE; Alam M
    Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
    Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
    Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
    Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
    Front Immunol; 2021; 12():800149. PubMed ID: 35126364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.
    Tan IJ; Ferrada MA; Ahmad S; Fike A; Quinn KA; Groarke EM; Beck DB; Allbritton J; Castelo-Soccio L; Young NS; Patel BA; Grayson PC; Cowen EW
    JAMA Dermatol; 2024 Aug; 160(8):822-829. PubMed ID: 38865133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow reinvestigation leading to the diagnosis of VEXAS syndrome.
    Strasser B; Kranewitter W; Hofer H; Haushofer A
    Lab Med; 2024 Sep; 55(5):655-657. PubMed ID: 38530637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.
    Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H
    Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.